EMA's Chmp: Positive Opinions to Update Composition of Mrna Vaccine Spikevax1, to Target Sars-Cov-2 Jn.1 Variant, Comirnaty for Kp.2 Subvariant
歐洲藥品管理局的Chmp:針對SARS-CoV-2 Jn.1變種更新mRNA疫苗Spikevax1的成分給予正面意見,針對Kp.2亞變種的Comirnaty
EMA's Chmp: Positive Opinions to Update Composition of Mrna Vaccine Spikevax1, to Target Sars-Cov-2 Jn.1 Variant, Comirnaty for Kp.2 Subvariant
歐洲藥品管理局的Chmp:針對SARS-CoV-2 Jn.1變種更新mRNA疫苗Spikevax1的成分給予正面意見,針對Kp.2亞變種的Comirnaty
譯文內容由第三人軟體翻譯。